about
Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling studyThe effects of maximising the UK's tobacco control score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study.Modeling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic DisparitiesEstimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study.A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study.Systematic review of dietary trans-fat reduction interventions.Socioeconomic Inequalities in Dietary Sodium Intake: Upstream Versus Downstream Interventions.Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.Fruit and vegetable consumption and non-communicable disease: time to update the ‘5 a day’ message?Health and Climate Impacts of Scaling Adoption of Liquefied Petroleum Gas (LPG) for Clean Household Cooking in Cameroon: A Modeling StudyUniversal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysisQuantifying the impact of the Public Health Responsibility Deal on salt intake, cardiovascular disease and gastric cancer burdens: interrupted time series and microsimulation studyFDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness AnalysisCost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health
P50
Q33703670-7E5733B5-4C56-4F81-A281-D9194C1BAC3AQ35347493-3F7DE3D4-A0DA-407E-A1E3-953033AB1235Q35976944-470BA0CB-3BF7-4EE7-84BF-24C994BE46D6Q36665145-47E8146B-FEEE-4198-B3A7-A20EF0F82B4EQ37612134-9218631B-B2A0-487A-B489-6982888089DEQ41131979-A0859165-BBE9-4827-8E07-EFF8A932E3C5Q47102586-24837F9E-78A6-4E30-965F-E3DA4E3CE326Q54090429-DBD38287-8442-4677-9234-ACC016DD8A91Q54962204-DAA00645-92C8-407E-A5CF-A7E61D1D0E2CQ54985794-AA5A9D09-5831-4B4A-AF7A-C417A7519967Q59621360-F7A8418E-B2D6-4725-A2B1-F0F0031AC1E9Q90794996-E8BD7A3A-7BAA-471E-BB22-DF90ACB5FDE8Q91071246-CB3B9A17-C3B6-4673-9DE9-EA3EFB99B215Q92001015-4C673EB2-CA7D-484A-B3FD-0A508629F437Q92098984-6B9F673E-8E14-4FB8-92BA-50637FC30601Q93078753-1D481099-0BF3-4C06-9763-044A02FB5026
P50
description
investigador
@es
researcher
@en
name
Chris Kypridemos
@en
type
label
Chris Kypridemos
@en
prefLabel
Chris Kypridemos
@en
P108
P31
P496
0000-0002-0746-9229